Author:
WANG Longsheng,ZHANG Wenxin,ZHANG Jie,ZHENG Mingming,PAN Xiaohui,GUO Hongjie,DING Ling
Publisher
China Science Publishing & Media Ltd.
Reference96 articles.
1. YI M, ZHENG X, NIU M. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions. Mol Cancer, 2022, 21:
2. MAJIDPOOR J, MORTEZAEE K. The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives. Clin Immunol, 2021, 226:
3. ZHANG Zhijing, ZHANG Qiyi, JIN Zuyi, et al. Progress for targeting adenosine A2A receptors in cancer immunotherapy[J]. Acta Pharmaceutica Sinica, 2022, 57(9): 2557-2569. (in Chinese).
4. 张芷菁, 张启怡, 金祖翼, 等. 靶向腺苷A2A受体的肿瘤免疫治疗研究进展[J]. 药学学报, 2022, 57(9): 2557-2569..
5. LIU H Y, WANG F H, LIANG J M. Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer. J Cancer Res Clin Oncol, 2023, 149: 2743-2756.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献